Genetic testing and molecular biology diagnostics have made considerable progress in recent years and play an important role in the detection and treatment of diseases. DNA tests and polymerase chain reaction (PCR) tests are two common methods used in molecular biology diagnostics to identify genetic alterations and investigate molecular biomarkers.
Genetic testing allows doctors and researchers to analyse genetic information of an individual and identify possible disease risks. By examining the genetic code, certain genetic mutations associated with diseases such as cancer, cardiovascular disease and genetic disorders can be detected. This information can be used to develop individual treatment plans and take preventive measures to reduce the risk of disease.
Molecular biomarkers are specific molecules that indicate genetic changes or biological processes. They can serve as indicators of specific diseases and allow early diagnosis and monitoring of disease progression. Molecular biomarkers can be identified and analysed through genetic testing and molecular diagnostic methods, providing physicians with valuable information about a patient's health status.
DNA tests play a crucial role in molecular diagnostics. With this method, specific DNA sequences can be identified and analysed. DNA tests are often used to examine genetic changes associated with certain diseases. In addition, they enable the determination of lineages and the prediction of genetic characteristics such as hair colour or eye colour.
The polymerase chain reaction (PCR) is a technique widely used in DNA analysis. It enables the rapid amplification of specific DNA sequences, which allows for more accurate analysis and examination. PCR is widely used in forensic genetics, infectious disease diagnostics and prenatal diagnostics. This method has significantly improved the efficiency and accuracy of genetic testing.
DCGen is a company that develops and services NGS-based multigene assays that can help patients and doctors make treatment decisions. DCGen has a technology to analyze DNA and RNA based on NGS
Pioneering molecular tests to improve clinical practice and patients' quality of life We develop leading innovative molecular diagnostic solutions tailored to the needs of diagnostic laboratories,
DIANA Biotechnologies is a Czech biotechnology company with strong in-house research and development. The company was founded in 2018 with the aim of developing applications of the patented DIANA
Diatech Pharmacogenetics is the Italian leader in the development, production and commercialisation of pharmacogenetics tests for cancer precision medicine. Founded in 1996, Diatech Pharmacogenetics
EDAN is dedicated to improving the human condition around the world by delivering value-driven, innovative, and high-quality medical products and services, pioneering a comprehensive line of medical
Established in 2015, EMVDL is a HK homegrown MedTech company formed by medical doctors, scientists & engineers. With a unique integration of expertise from our multidisciplinary professionals,
French actor in In Vitro Diagnostics The Eurobio scientific group, resulting from the acquisition by Exonhit of Ingen in 2012 and Eurobio in 2017, is a French fully integrated leader in the field of
ONE-STOP SOLUTION AND INNOVATIVE Our team of engineers has developed a state-of-the-art solution for remote pathological examinations of macroscopic specimens and microscopic slides. This solution is
Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials,
FlashDx's proprietary semi-Solid Phase Real Time PCR (sSPRT™) technologies enables customers to achieve lab standard quality data for molecular testing in a near patient care setting. Paired with our
The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering. One of the
The Fraunhofer-Institut für Mikrotechnik und Mikrosysteme IMM is part of the Fraunhofer-Gesellschaft e.V. - the world's leading organization for application-oriented research. The DIAGNOSTICS
Our goal is to make the fastest possible quality diagnostics accessible to everyone, everywhere, and to enable the right treatment at the right time. Therefore, all our MDx technologies are developed
GeneAll is a leading manufacturer of molecular biology products based in Korea. We are the second-largest market player in Korea, following Qiagen, in the field of manual extraction kits. With well
GeneCker provides the standardization of liquid biopsy cancer diagnosis based on CRISPR/Cas9. Business Field: • Focus: CRISPR/Cas9-based cancer diagnosis • Specialization: CRISPR/Cas9 cancer
Manchester,
United Kingdom of Great Britain and Northern Ireland
Genedrive is a molecular diagnostics company developing and commercialising rapid point of care tests for use in patient stratification (genotyping). In 2022, Genedrive deployed the world’s
Genekam Biotechnology AG is a company specialised on the following fields: pandemic virology, immunology as well as stem cells. It has around 700 different PCR kits for different targets. It covers
Molecular diagnostic technologies of Genematrix including C-TAG, Omniplex, EnCleap, TriO, REMP are applied to diseases such as hepatitis B, hepatitis C, cervical cancer, sexually transmitted
GeneProof, now a proud member of Nuvinka Dx, will be exhibiting at this year’s MEDICA Fair alongside ALPCO. Nuvinka Dx unites both GeneProof and ALPCO, bringing together expertise in diagnostic